Autor: |
André Ibrahim, David, Luiz Arnaldo, Szutan, Jeffrey, Gaynor, Phillip, Ruiz, Gennaro, Selvaggi, Panagiotis, Tryphonopoulos, Gary, Kleiner, Jang I, Moon, Seigo, Nishida, Debbie, Weppler, Violet, Squenazi, Lobella, Conanan, David M, Levi, Tomoaki, Kato, Andreas G, Tzakis |
Rok vydání: |
2007 |
Předmět: |
|
Zdroj: |
Revista da Associacao Medica Brasileira (1992). 54(5) |
ISSN: |
0104-4230 |
Popis: |
A biochemical marker for detection of acute cellular rejection following small intestine transplantation has been sought. Citrulline, a non- protein amino acid synthesized mainly by functioning enterocytes, has been proposed. Trial sensitivity has been reportedly high but with low specificity. Thus, the goal was to determine, in a sufficiently large analysis, the significant value of citrulline level in the post-transplant setting, which would correlate with complications such as rejection and infection.Since March, 2004 2,135 dried blood spot (DBS) citrulline samples were obtained from 57 small intestine transplant recipients three months or more after post-transplant, i.e., once the expected period of recovery in the citrulline levels had occurred.Using a13 vs.13 micromoles/L cut off point, sensitivity of DBS citrulline for the detection of moderate or severe ACR was extremely high (96.4%). Furthermore, specificity estimates (given the absence of ACR and these particular infections), while controlling for time-to-DBS sample were reasonably high (54%-74% in children and 83%-88% in adults), and the negative predictive value (NPV) was99%.Citrulline is a non-invasive marker to evaluate problems of the intestinal graft after three months post-transplant. Due to the high NPV, a moderate or severe ACR can be ruled out, based exclusively on knowledge of a high value for DBS citrulline. |
Databáze: |
OpenAIRE |
Externí odkaz: |
|